06.15.21

Two Shots of Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Delta Variant: Study

Source: FiercePharma

A real world study conducted by Public Health England shows that two doses of the vaccines produced by Pfizer-BioNTech and AstraZeneca are highly effective in preventing hospitalizations due to the troublesome Delta variant (B.1.617.2), which scientists first detected in India. The variant has become the predominant coronavirus strain in the UK, according to a FiercePharma report

Of those who received two doses of the Pfizer-BioNTech vaccine, 96% avoided hospitalization with no deaths. Of those who received two shots of the AZ vaccine, 92% avoided hospitalization with no deaths.

Read the full article. 

Related Content